Eric Lefkofsky’s move of treating Cancer at Tempus

Modern improvements in the health sector have resulted in more effective treatments for numerous cardiovascular and infectious diseases. This has dramatically increased the life expectancy of people in the United States. The recent years have seen significant improvements in the treatment and screening of individuals diagnosed with cancer. These upgrades have driven the need for cancer-based measures to increase medical care for people living with the disease.

After a well-established analysis of the Surveillance, Epidemiology, and End Results (SEER) cancer registries, scientists found that the cancer prevalence varied by the patient’s age. The type of cancer also varied by the age of the patients. SEER is doing all it can to differentiate new cancers from metastatic or recurrent ones, to reduce doctors from mistaking the new ones from the recurrent ones. It is, however, difficult to distinguish them as they are dependent on factors like the patient’s prevalence of tobacco use and SEER’s new approach to medical practice.

The analysis also helps to improve care for cancer patients. It also explains the importance of taking both a holistic and nuanced approach to health care when it comes to treating cancer. Careful attention to the general health of patients is vital. This is important as every cancer patient counts.

Erick Lefkosky is the co-founder of Tempus, a technology company that is working towards fighting the battle against cancer. He is also the chairman and co-founder of Groupon, a global e-commerce marketplace. Erick has dedicated his life towards cancer research. He has been working with Tempus to build a health-tech infrastructure that modernizes the treatment of the epidemic. His love and care for cancer patients have made him be motivated to battle the disease.

He and his wife went on to form a charitable trust, which supports charitable and educational organizations in the world. Tempus, the company he works at, focuses on collecting and analyzing data using proprietary algorithms and statistical analysis to find opportunities to help a patient’s physician in providing accurate and personalized medicine. Its primary goal is to help doctors to develop better treatment and care plan for patients.


Leave a Reply

Your email address will not be published. Required fields are marked *